v.l.n.r. Sabrina LEIGHEB, Maria TOTH, Mahbod MOUSAVIAN Aida TLEUOVA, Francois DU PLESSIS (Boehringer Inghelheim, Associate Director, Gene Therapy, Research Beyond Borders), Maral RAHIMZADEH, Reingard GRABHERR, Alexander BRIX (Boehringer Inghelheim, Lab Head “Drug Substances”), Bernd REHBERGER (Boehringer Inghelheim, Lab Head “Development Biologicals” & “Automation”), Udo MAIER (Boehringer Inghelheim, Head of Research Beyond Borders Europe), Astrid DÜRAUER, Head CD Laboratory, Georg SMESNIK, Mark DÜRKOP (Novasign, CEO), Robin NILSSON (Boehringer Inghelheim, ) Till WENGER, Company Representative (Boehringer Ingelheim, Head of Development Core Technologies), Maximilian KRIPPL (Novasign), Nikolaus VIRGOLINI, Theresa SCHARL, Petra POLAK, Patricia PEREIRA AGUILAR (acib GmbH)